Varicella zoster vaccine (live/attenuated)
- Generic Name
- Varicella zoster vaccine (live/attenuated)
- Brand Names
- Proquad, Varivax, Zostavax
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- GPV39ZGD8C
- Background
Live attenuated zoster vaccine is available as two products: Zostavax for the prevention of shingles in immunocompetent people over the age of 50, and Varivax for the prevention of chickenpox in individuals 12 months of age and older. While the two vaccines contain the same immunological components and provide protection against the same virus, Zostavax cont...
- Indication
Zostavax vaccine is indicated for the prevention of herpes zoster (shingles) in immunocompetent adults aged 50 years and older.
Varivax vaccine is indicated for active immunization for the prevention of varicella in individuals 12 months of age and older.
- Associated Conditions
- Herpes Zoster, Varicella Zoster Virus Infection
- Associated Therapies
- -
Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US
- Conditions
- Interventions
- Biological: MenACYW conjugate vaccineBiological: MenACYW-135 conjugate vaccineBiological: DTaP-IPV//Hib vaccineBiological: Pneumococcal 13-valent conjugate vaccineBiological: Pentavalent rotavirus vaccineBiological: Hepatitis B vaccineBiological: Measles, mumps, rubella (MMR) vaccineBiological: Varicella vaccineBiological: Hepatitis A vaccine
- First Posted Date
- 2018-05-25
- Last Posted Date
- 2024-10-14
- Lead Sponsor
- Sanofi Pasteur, a Sanofi Company
- Target Recruit Count
- 2627
- Registration Number
- NCT03537508
- Locations
- 🇺🇸
Helios Clinical Research Site Number : 8400109, Houston, Texas, United States
🇺🇸Wee Care Pediatrics Syracuse Site Number : 8400024, Syracuse, Utah, United States
🇺🇸Birmingham Pediatric Associates Site Number : 8400026, Birmingham, Alabama, United States
A Study of MG1111 in Healthy Children
- First Posted Date
- 2017-12-18
- Last Posted Date
- 2021-05-14
- Lead Sponsor
- Green Cross Corporation
- Target Recruit Count
- 814
- Registration Number
- NCT03375502
- Locations
- 🇰🇷
The catholic university of Korea, Seoul st. mary's hospital, Banpo-dong, Seoul, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.